AbClon Inc.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.abclon.com

Country

South Korea

Exchange

KOSDAQ

Founded 2010

AbClon provides the research and development of antibody drugs in South Korea and Sweden. The company's products in pipeline include NEST platform technology products for breast and gastric cancers.

Its portfolio also includes AffiMab platform technology products for colon cancer and autoimmune diseases, and CAR-T platform technology products for hematologic and ovarian cancers. Founded in 2010, AbClon is based in Seoul, South Korea.

Key Stats

52-Week Range

₩9770.00₩95800.00

Beta0.74

Trailing P/EN/A

Forward P/EN/A

Trailing EPSN/A

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.